Want to track STX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Shield Therapeutics PLC (STX) Statistics
Valuation metrics
Market Cap -
Enterprise value 104.95M
Trailing P/E (ttm) -8.43
Forward P/E -
PEG ratio -0.08
Price/Sales (ttm) 1.51
Price/Book (mrq) -5.16
Enterprise Value/Revenue 1.79
Enterprise Value/EBITDA -32.01
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 3.77M
Average volume (90 days) 2.28M
Price summary
52-Week low 0
52-Week high 0
Beta -
50-Day moving average 5.09
200-Day moving average 7.12
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 7 Jul 2026
Ex-Dividend Date 24 Jun 2026
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.18%
Operating margin -0.07%
Operational effectiveness
Return on assets -0.19%
Return on equity 0.65%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.05
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.01
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.01
Total debt (mrq) -
Total Debt/Equity (mrq) -1.46
Current ratio (mrq) 0.75%
Book value per share (mrq) -0.02
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
